Apple Launches its Watch Series 4 Enabled with ECG App and Irregular Rhythm Notification in Europe and Hong Kong
Shots:
- The ECG app on Apple Watch Series 4 is evaluated in 600 patients resulted in 98.3% sensitivity in classifying AFib- 99.6% specificity in classifying sinus rhythm- 87.8% of recordings classified by the ECG app
- The irregular rhythm notification function was assessed in the Apple Heart study enrolled with 400-000 candidates and demonstrated 0.5% irregular pulse notifications- identified heart rate irregularities with confirmed AFib
- Watch Series 4 with OS 5.2 possess health app with irregular rhythm notification enables customers to produce ECG on demand & check user’s heart rhythm using the optical heart sensor- available in 19 EU countries and has received FDA’s De Novo clearance in the US
Ref: Apple | Image: Geeky Gadgets
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com